AST-3424

AST-3424 · Ascentawits Pharmaceuticals, Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AST-3424, covering 2025-02-25 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma [Phase 2]